This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Biogen Ma Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovations of Steven Andrew Lantz
Introduction
Steven Andrew Lantz is an accomplished inventor based in Jamaica Plain, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Alzheimer's disease. His innovative work focuses on developing compositions that target beta-amyloid, a protein associated with cognitive decline.
Latest Patents
Lantz holds a patent for "Pharmaceutical compositions containing anti-beta amyloid antibodies." This patent addresses the need for effective treatments for the abnormal accumulation of beta-amyloid in the central nervous system. The pharmaceutical compositions he developed are aimed at treating mild cognitive impairment and Alzheimer's disease-associated disorders.
Career Highlights
Steven Lantz is currently associated with Biogen MA Inc., a leading biotechnology company known for its focus on neurological diseases. His work at Biogen has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Lantz has collaborated with notable colleagues, including Kapil Gupta and Shantanu Sule. These partnerships have enhanced the research efforts in developing effective treatments for Alzheimer's disease.
Conclusion
Steven Andrew Lantz's innovative contributions to pharmaceutical compositions demonstrate his commitment to addressing critical health challenges. His work continues to pave the way for advancements in the treatment of Alzheimer's disease and related disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile